Matthew Ziegler, MD, MSCE
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
3 Silverstein Pavilion, 3400 Spruce Street
Philadelphia, PA 19104
Philadelphia, PA 19104
Email:
mattz@pennmedicine.upenn.edu
mattz@pennmedicine.upenn.edu
Publications
Education:
BA (Biology)
Saint Louis University, 2008.
MD
University of Wisconsin School of Medicine, 2012.
MS (Clinical Epidemiology)
University of Pennsylvania, 2018.
Permanent linkBA (Biology)
Saint Louis University, 2008.
MD
University of Wisconsin School of Medicine, 2012.
MS (Clinical Epidemiology)
University of Pennsylvania, 2018.
Description of Clinical Expertise
Infectious diseases in patients with hematologic malignancy.Description of Research Expertise
Healthcare-associated infections in patients with hematologic malignancy.Transmission of multi-drug resistant organisms within the hospital environment.
Selected Publications
Ziegler M, Kelly B, David M, Dutcher L, Tolomeo O, Bekele S, Loughrey S, Glaser L, Lautenbach E: Patient to environment transmission of multidrug-resistant bacteria within intensive care units. Oral Abstract Presentation. Infectious Disease Society of America IDWeek 2020. Philadelphia, PA October 2020.Ziegler M, Pegues D, Landsburg D, Gaynes S, Desphy-Carter A, Omorogbe J, Gilmar C, Tolomeo P, Gorman T, Palmer M, Harker C, Lautenbach E, Han J: Enhanced environmental cleaning to reduce rates of Clostridioides difficile infection on oncology units. Society for Healthcare Epidemiology of America Decennial Conference April 2020 Notes: Accepted for presentation at the April 2020 SHEA Decennial Meeting.
Calderwood, M. S., Deloney, V. M., Anderson, D. J., Cheng, V. C., Gohil, S., Kwon, J. H., Mody, L., Monsees, E., Vaughn, V. M., Wiemken, T. L., Ziegler, M. J., Lofgren, E.: Policies and practices of SHEA Research Network hospitals during the COVID-19 pandemic. Infect Control Hosp Epidemiol 41(10): 1127-1135, 2020.
Ziegler M, Freyer C, Landsburg D, Pegues D, Bilker W, Hirsh R, Kucharczuk C, Gilmar C, Gorman T, Palmer M, Harker C, Lightheart E, Han JH : Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units; a multidisciplinary intervention for reducing Clostridioides difficile risk. Infect Control Hosp Epidemiol 40(11): 1294-1296, Nov 2019.
Ziegler M, Han JH, Landsburg D, Pegues D, Reesey E, Gilmar C, Gorman T, Bink K, Moore A, Kelly BJ: Impact of levofloxacin for the prophylaxis of bloodstream infection on the gut microbiome in patients with hematologic malignancy. Open Forum Infect Dis 6(7): ofz252, Jul 2019.
Ziegler M, Landsburg D, Pegues D, Bilker W, Gilmar C, Kucharczuk C, Gorman T, Bink K, Moore A, Fitzpatrick R, Stadtmauer EA, Mangan P, Kraus K, Han JH: Fluoroquinolone prophylaxis is highly effective for the prevention of central line-associated bloodstream infections in autologous stem cell transplant patients. Biol Blood Marrow Transplant 25(5): 1004-1010, May 2019.
Ziegler M, Freyer C, Landsburg D, Pegues D, Hirsh R, Kucharczuk C, Gilmar C, Gorman T, Palmer M, Harker C, Lightheart E, Han J: Guiding appropriate acid suppression in hematology-oncology units. Society for Healthcare Epidemiology of America Annual Meeting April 2019 Notes: Oral Abstract Presentation.
Ziegler M, Han J, Landsburg D, Pegues D, Reesey E, Gilmar C, Gorman T, Bink K, Moore A, Kelly B: Impact of levofloxacin for the prophylaxis of bloodstream infection on the gut microbiome in patients with hematologic malignancy. Annual IDWeek Meeting Infectious Diseases Society of America, San Francisco, CA October 2018.
Ziegler M, Landsburg D, Pegues D, Alby K, Gilmar C, Bink K, Gorman T, Moore A, Bonhomme B, Omorogbe J, Tango D, Tolomeo P, Han JH: Clinical characteristics and outcomes of hematologic malignancy patients With positive Clostridium difficile toxin immunoassay versus polymerase chain reaction test results. Infect Control Hosp Epidemiol 39(7): 863-866, Jul 2018.
Ruggero MA, Ziegler MJ, Tebas P, Binkley A, Kelly BJ: Successful treatment of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis with outpatient oritavancin therapy. Infect Dis Clin Pract 26(3): 141-144, May 2018.